• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Bain-backed Car­du­ri­on rais­es $260M to fund ex-Imara drug, buy more car­dio as­sets

10 months ago
Financing
Startups

Af­ter last year's Im­muno­Gen pact, Ver­tex finds an­oth­er con­di­tion­ing agent part­ner in Orum

10 months ago
Startups
Deals

Ger­man biotech CatalYm rais­es $150M to re­pur­pose obe­si­ty tar­get for can­cer

10 months ago
Financing

Ver­tex takes fed­er­al gov­ern­ment to court over Cas­gevy fer­til­i­ty treat­ment pro­gram

10 months ago
Pharma
Law

Alzheimer's biotech As­ceneu­ron rais­es $100M to see if it can com­pete with Lil­ly, Bio­gen on tau

10 months ago
Financing
Startups

Cor­den­Phar­ma in­jects €900M to boost GLP-1 man­u­fac­tur­ing in US and Eu­rope

10 months ago
Manufacturing

Ex­clu­sive: Kins rais­es $7M to ex­pand in-home and vir­tu­al phys­i­cal ther­a­py

10 months ago
Financing
Startups

Roche de­tails ear­ly obe­si­ty da­ta from GLP-1/GIP ag­o­nist, plans for Phase 2 study this year

10 months ago
R&D

Fac­ing a tepid Alzheimer’s mar­ket, Lil­ly looks to build ‘a sense of ur­gency’ to jump­start sales of do­nanemab

10 months ago
Pharma

J&J calls pro­posed class ac­tion talc suit 'mer­it­less' as set­tle­ment vote dead­line nears

10 months ago
Pharma
Law

EMA warns pa­tients to tell doc­tors about GLP-1 us­age be­fore surgery

10 months ago
Pharma
FDA+

Rev­o­lu­tion Med­i­ci­nes' RAS in­hibitor shows promise in ear­ly-stage pan­cre­at­ic can­cer tri­al

10 months ago
R&D

Evofem inks women’s health deal; Aus­per­Bio brings in $37M

10 months ago
News Briefing

Up­dat­ed: Lex­eo Ther­a­peu­tic­s' gene ther­a­py shows po­ten­tial for Friedre­ich's atax­ia car­diomy­opa­thy with ear­ly da­ta

10 months ago
R&D
Cell/Gene Tx

Arti­va aims for $116M in sec­ond at­tempt at IPO to boost NK cell ther­a­py pipeline

10 months ago
Financing
Cell/Gene Tx

GSK HQ of­fi­cial­ly re­turns to cen­tral Lon­don af­ter decades in city’s sub­urbs

10 months ago
Pharma

Deep dive on pay pack­ages; Lil­ly strikes $3.2B buy­out; Pfiz­er’s R&D head to de­part; and more

10 months ago
Weekly

Lil­ly says lu­pus drug dropped from pipeline failed to show ef­fi­ca­cy

10 months ago
R&D
Pharma

In­di­v­ior ax­es schiz­o­phre­nia drug and shrinks rev­enue guid­ance

10 months ago
R&D
Pharma

Two health­care SPACs go pub­lic, with sev­er­al more on the hunt for deals

10 months ago
Financing
Deals

How SCO­TUS' de­ci­sion in Chevron could change the way the FDA reg­u­lates bio­phar­ma

10 months ago
FDA+
Law

Metageno­mi sci­ence chief de­parts, just a few months af­ter IPO

10 months ago
People
Startups

Ideaya rais­es $302M; Ab­b­Vie to seek ap­proval in gi­ant cell ar­teri­tis

10 months ago
News Briefing

Spin­outs, pen­sion re­forms and a GSK vet in cab­i­net: What the new UK gov­ern­ment could mean for life sci­ences

10 months ago
Financing
Startups
First page Previous page 123124125126127128129 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times